文献速递生殖医学

PLCZ1新突变导致受精失败或受精不良的男性不育

Novel mutations in PLCZ1 cause male infertility due to fertilization failure or poor fertilization.
PubMed 文献 · Hum Reprod · 2020-01-01

该研究纳入14例表现为完全受精失败或受精不良的原发性不育男性,通过Sanger测序检测PLCZ1全外显子,在5例患者中鉴定出6个新突变和1个已报道突变。突变导致精子PLCZ1蛋白表达缺失,突变型cRNA注射人MII卵母细胞后原核形成比例显著下降,提示突变损害蛋白功能。人工卵母细胞激活治疗成功挽救4例患者的受精失败表型并分娩3名健康婴儿。

要点

  • 对ICSI后完全受精失败或受精不良的男性不育患者,可考虑筛查PLCZ1基因突变。
  • PLCZ1突变可导致精子PLCZ1蛋白表达缺失,突变型cRNA注射人MII卵母细胞后原核形成比例显著下降。
  • 人工卵母细胞激活可挽救部分PLCZ1突变患者的受精失败表型。

核心结论

  • 在14个独立家系中5例受精失败或受精不良患者携带PLCZ1突变,提示这些突变可能导致原发性不育男性的受精失败。

研究设计与样本

  • 提取患者外周血基因组DNA,对PLCZ1全外显子进行Sanger测序,用CodonCode软件比对序列以识别罕见变异,并用ExAC数据库检索相应突变频率。
  • 通过生物信息学预测变异致病性及对蛋白的可能影响,用western blotting评估精液样本中PLCZ1蛋白水平,并将野生型和突变型PLCZ1 cRNA注射入人成熟MII卵母细胞以评估卵母细胞激活能力。

主要发现

  • 在5例受影响个体中鉴定出PLCZ1的6个新突变和1个已报道突变,除4个新错义突变外,还发现两种新变异类型:1个框内缺失和1个剪接突变。
  • Western blot分析显示,5例受影响患者的精液样本中未观察到PLCZ1蛋白表达。
  • 微量注射PLCZ1 cRNA变异体后,4个新错义突变和1个新框内缺失突变导致原核百分比显著下降,提示这些突变对蛋白功能有有害影响。

关键数值与推荐

  • 通过人工卵母细胞激活治疗,4例受影响患者的受精失败表型被成功挽救,并分娩3名健康婴儿。

临床怎么用

  • 对ICSI后完全受精失败或受精不良的男性不育患者,可进行PLCZ1基因检测以辅助诊断。
  • 携带PLCZ1突变的患者可考虑采用人工卵母细胞激活治疗以改善受精结局。

局限性

  • 本研究仅筛查了PLCZ1的全外显子,PLCZ1非编码区可能存在的其他突变有待进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do sperm-specific phospholipase C zeta (PLCZ1) mutations account for male infertility due to fertilization failure? SUMMARY ANSWER: Six novel mutations and one reported mutation in PLCZ1 were identified in five of 14 independent families characterized by fertilization failure or poor fertilization, suggesting that these mutations may be responsible for fertilization failure in men exhibiting primary infertility. WHAT IS KNOWN ALREADY: PLCZ1 is essential for the induction of intracellular calcium (Ca2+) oscillations and the initiation of oocyte activation during mammalian fertilization. However, genetic evidence linking PLCZ1 mutations with male infertility remains limited. STUDY DESIGN, SIZE, DURATION: Fourteen unrelated primary infertility patients were recruited into this study from January 2016 to December 2018; the patients exhibited total fertilization failure or poor fertilization, as evidenced by ICSI and sperm-related oocyte activation deficiencies identified in mouse oocyte activation assays. PARTICIPANTS/MATERIALS, SETTING, METHODS: Genomic DNA samples were extracted from the peripheral blood of patients. The whole exons of PLCZ1 were sequenced by Sanger sequencing. The PLCZ1 sequences were aligned by CodonCode software to identify rare variants. The ExAC database was used to search for the frequency of corresponding mutations. The pathogenicity of identified variants and their possible effects on the protein were assessed in silico. PLCZ1 protein levels in semen samples were evaluated by western blotting. Oocyte activation ability was assessed by the injection of wild-type and mutant PLCZ1 cRNAs into human mature metaphase II (MII) oocytes in vitro. MAIN RESULTS AND THE ROLE OF CHANCE: We identified six novel mutations and one reported mutation in PLCZ1 among five affected individuals. In addition to four novel missense mutations, two new types of genetic variants were identified, including one in-frame deletion and one splicing mutation. Western blot analysis revealed that PLCZ1 protein expression was not observed in the semen samples from the five affected patients. Microinjection with the PLCZ1 cRNA variants was performed, and a significant decrease in the percentage of pronuclei was observed for four novel missense mutations and one novel in-frame deletion mutation, suggesting that these mutations have a deleterious influence on protein function. By artificial oocyte activation treatment, the fertilization failure phenotypes of four affected patients were successfully rescued and three healthy babies were delivered. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: We screened only the whole exons of PLCZ1. Additional possible mutations in the non-coding region of PLCZ1 should be further studied. WIDER IMPLICATIONS OF THE FINDINGS: Our study not only further confirms the important role of PLCZ1 in human fertilization but also expands the mutational spectrum of PLCZ1 associated with male infertility, which provides a basis for assessing genetic variation in PLCZ1 as a potential diagnostic marker for infertile men suffering from fertilization failure. STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the National Natural Foundation of China (81 571 486 and 81 771 649). All authors have no conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Yan Z, Fan Y, Wang F, et al. Novel mutations in PLCZ1 cause male infertility due to fertilization failure or poor fertilization. Hum Reprod. 2020. PMID: 32048714. doi:10.1093/humrep/dez282

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。